compound 13 [PMID: 15925511]   Click here for help

GtoPdb Ligand ID: 8188

Compound class: Synthetic organic
Comment: Compound 13 is a derivative assessed in a medicinal chemistry study to identify novel selective inhibitors of SRSF protein kinase 1 (SRPK1) [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 119.56
Molecular weight 388.03
XLogP 4.03
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(=O)c1ccc2c(c1)cc1c(c2)nc(c(n1)c1cccs1)c1cccs1
Isomeric SMILES OC(=O)c1ccc2c(c1)cc1c(c2)nc(c(n1)c1cccs1)c1cccs1
InChI InChI=1S/C21H12N2O2S2/c24-21(25)13-6-5-12-10-15-16(11-14(12)9-13)23-20(18-4-2-8-27-18)19(22-15)17-3-1-7-26-17/h1-11H,(H,24,25)
InChI Key GXGUVSXXUOACEX-UHFFFAOYSA-N
References
1. Székelyhidi Z, Pató J, Wáczek F, Bánhegyi P, Hegymegi-Barakonyi B, Erös D, Mészáros G, Hollósy F, Hafenbradl D, Obert S et al.. (2005)
Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives.
Bioorg Med Chem Lett, 15 (13): 3241-6. [PMID:15925511]